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http://www.molecularbrain.com/content/6/1/17RESEARCH Open AccessConsolidation of auditory fear memories formed
by weak unconditioned stimuli requires NMDA
receptor activation and de novo protein synthesis
in the striatum
Ayumi Kishioka1, Takeshi Uemura1,2, Fumiaki Fukushima1 and Masayoshi Mishina1,3*Abstract
Background: Fear is one of the most potent emotional experiences and is an adaptive component of response to
potentially threatening stimuli. Cumulative evidence suggests that the amygdala plays a central role in the
acquisition, storage and expression of fear memory. We previously showed that the selective ablation of striatal
neurons in the adult brain impairs the long-term, but not short-term, memory for auditory fear conditioning with a
lower-intensity footshock. This finding raises an intriguing possibility that long-term auditory fear memory may be
consolidated in the striatum.
Results: There was a significant difference in the freezing responses between two groups of mice subjected to
paired and unpaired conditioning, indicating that the auditory fear conditioning with a lower-intensity footshock is
an associative learning. Post-conditioning infusion of NMDA receptor inhibitors into the striatum suppressed the
consolidation of auditory fear memory when mice were conditioned with a low-intensity footshock. Furthermore,
intra-striatum infusion of protein synthesis blocker anisomycin immediately or 1 h after the conditioning prevented
the formation of auditory fear memory. On the other hand, the infusion of anisomycin 3 h after conditioning
exerted little effect on the auditory fear conditioning, consistent with the presence of a critical time window of
protein synthesis for memory consolidation.
Conclusions: These results suggest that NMDA receptors and de novo protein synthesis in the striatum are crucial
for the consolidation of auditory fear memory formed with a low-intensity unconditioned stimulus.
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Fear is one of the most potent emotional experiences of
our lifetime and is an adaptive component of response
to potentially threatening stimuli, serving a function that
is critical to the survival of higher vertebrates [1,2].
Animals can learn that specific sensory cues in the envi-
ronment predict aversive events through a form of asso-
ciative learning termed fear conditioning. The memory
of learned fear can be assessed quantitatively using a* Correspondence: mmishina@fc.ritsumei.ac.jp
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reproduction in any medium, provided the orPavlovian fear-conditioning paradigm [3]. The amygdala
plays an essential role in the acquisition, storage and ex-
pression of fear memories [1-4]. Blockade of N-methyl-D-
aspartate (NMDA) receptors in the amygdala suppresses
the acquisition of auditory fear conditioning [5,6], while
the formation of long-term auditory fear memory can
be disrupted by the treatment of protein synthesis in-
hibitors [7].
The striatum is regarded as a key forebrain structure
underlying appetitive learning and memory [8]. NMDA
receptors in the striatum are required for the consoli-
dation of appetitive Pavlovian learning [9,10] and the
acquisition of instrumental learning [11,12]. De novo
protein synthesis in the striatum is also required for thel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Auditory fear conditioning with a lower-intensity
footshock is associative in nature. (A) Schema of fear
conditioning in the paired or unpaired paradigm. In the paired
conditioning paradigm, mice were placed in the conditioning
chamber for 2 min and then presented with a tone for 1 min. At the
end of the tone presentation, the mice were given a scrambled
electrical footshock (0.3 mA, 1 s). One minute after footshock, the
mice were returned to their home cages. In the unpaired
conditioning paradigm, mice received the footshock immediately
after placement in the conditioning chamber. Two and half minutes
after the placement, a tone was presented for 1 min. Half minute
later, mice were returned to their home cages. Twenty-four hours
after conditioning, mice were placed in a novel chamber for 3 min
and then the tone was presented for 3 min. (B) Freezing responses
of paired group (filled circles, n = 7) on the conditioning (left) and
test (right) days. (C) Freezing responses of unpaired group (open
circles, n = 6) on the conditioning (left) and test (right) days. Arrows
and solid lines indicate footshock and tone, respectively.
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learning [13,14]. Previously, we developed an inducible
striatal neuron ablation system using transgenic mice
and revealed that the ablation of striatal neurons in-
duced in the adult brain impaired the formation of long-
term, but not short-term, auditory fear memory when
conditioned with a weak unconditioned stimulus (US)
[15]. Furthermore, post-conditioning ablation of striatal
neurons after memory formation diminished the audi-
tory fear memory [15]. These findings raise an intriguing
possibility that long-term auditory fear memory may be
consolidated at least partly in the striatum. Here, we
examined the issue by administration of NMDA re-
ceptor antagonists and protein synthesis inhibitor into
the striatum during auditory fear conditioning. Our
results showed that the consolidation of auditory fear
memories formed with a low-intensity US required post-
conditioning NMDA receptor activation and de novo pro-
tein synthesis in the striatum.
Results
Auditory fear conditioning with a low-intensity footshock
We compared the freezing responses of mice in paired
and unpaired paradigms with a low-intensity US
(Figure 1A). In the paired paradigm, mice were placed
in a conditioning chamber for 2 min and then a tone
(65 dB, 10 kHz) was presented for 1 min. At the end
of the tone presentation, the mice were given a low-
intensity footshock (0.3 mA, 1 s). In the unpaired para-
digm, the low-intensity footshock was given immediately
after mice were placed in the conditioning chamber and
2.5 min after the placement, the tone was presented for
1 min. Twenty-four hours later, the animals were placed
in a novel chamber for 3 min and then the tone was
presented for 3 min. Mice conditioned with the paired
paradigm showed strong freezing responses upon tone
presentation (Figure 1B). In contrast, mice given unpaired
conditioning exhibited little freezing response to the tone
(Figure 1C). There was a significant difference in the free-
zing responses between two groups of mice (F1,11 = 40.3,
P < 0.001, n = 6 (paired) or 7 (unpaired), repeated mea-
sures ANOVA). We thus confirmed that the auditory fear
conditioning with a lower-intensity footshock is an asso-
ciative learning.
Intra-striatum infusion of APV impaired the formation of
auditory fear memory
NMDA receptors are critically involved in learning and
memory [16]. Here, we tested whether the activation of
striatal NMDA receptors occurs during the consolidation
period after the conditioning event. Mice received intra-
striatum cannula implantations several days before be-
havioral experiments. We first monitored the dye spread
in intra-striatum infusions. Dye solution (0.5 μl) spreadslargely in the nucleus accumbens (NAc) and along the
cannula track in the overlying caudate putamen (CP)
(Figure 2A). Dye solution in the NAc usually spreads
1.07 ± 0.08 mm laterally and 1.31 ± 0.11 mm verti-
cally (n = 6). It should be noted that the dye did not
spread to the basolateral amygdala (BLA) and central
Figure 2 Post-training infusion of APV into the striatum
impaired long-term fear memory. (A) Examination of dye spread
in the striatum. Bright field photomicrograph of colonal brain
sections showing the spread of the dye solution (0.5 μl) in the
striatum. An angled line indicates a track of guide cannula. (Left)
Dye solution spreads largely in the NAc and along the cannula track
in the overlying CP. (Middle) Dye solution in the NAc usually
spreads vertically as well (n = 6). (Right) Dye solution did not reach
the BLA or CeA. Scale bar: 1 mm. (B) Experimental design. Mice were
injected with 0.5 μl of ACSF or APV into the striatum immediately
after auditory fear conditioning with a lower-intensity footshock, and
tested 24 h later. (C) Freezing responses of ACSF (n = 10) and APV
(n = 10) groups on the conditioning (left) and test (right) days.
A solid line and a thin arrow represent tone and footshock (0.3 mA),
respectively. (D) Freezing responses of ACSF (n = 15) and APV
(n = 12) groups on the conditioning (left) and test (right) days. A
solid line and a thick arrow represent tone and footshock
(1.0 mA), respectively.
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conditioning (Figure 2A).
Mice were trained using the auditory fear conditio-
ning with a low-intensity footshock (0.3 mA) as above,
and immediately after conditioning, they received intra-
striatum infusion of NMDA receptor antagonist APV
(1 μg in 0.5 μl) [1,17] (Figure 2B). When tested 24 h after
conditioning, the freezing levels of APV-treated group
were significantly smaller than those of ACSF-treated one
(Figure 2C; F1,18 = 5.3, P = 0.034, n = 10 each, repeated
measures ANOVA). Thus, the post-training infusion of
APV in the stratum disrupted the formation of auditory
fear memory.
Induced ablation of striatal neurons impaired the forma-
tion of long-term auditory fear memory when mice were
conditioned with a lower-intensity, but not high-intensity,
footshock [15]. Mice were trained with a high-intensity
footshock (1.0 mA), and then received intra-striatum infu-
sion of APV (Figure 2D). Twenty-four hours after the con-
ditioning, the freezing levels were comparable between
ACSF- and APV-treated groups (Figure 2D; F1,25 = 0.76,
P = 0.39, ACSF, n = 15, APV, n = 12, repeated measures
ANOVA). There were no significant differences in the
freezing levels during tone presentation between ACSF-
treated groups with low and high intensity footshocks
(Figure 2C,D; F1,23 = 0.73, P = 0.40, ACSF-0.3 mA, n = 10
(0.3 mA) or 15 (1.0 mA), repeated measures ANOVA).
Thus, striatal NMDA receptors are required for the for-
mation of auditory fear memory with a low-intensity foot-
shock but not for the formation of auditory fear memory
with a high-intensity footshock.
We further tested the effect of GluRε2/GluN2B-selec-
tive NMDA receptor antagonist ifenprodil [18] on the
formation of auditory fear memory. Immediately after
auditory fear conditioning with a lower-intensity foot-
shock (0.3 mA), mice received intra-striatum infusion
of ACSF or ifenprodil (1 μg in 0.5 μl; see [19]). There
was a significant difference in the extent of the freezing
responses between ACSF- and ifenprodil-treated mice
(Figure 3A, B). When conditioned with a high-intensity
footshock (1.0 mA), however, the freezing responses of
both groups of mice were comparable (Figure 3C). These
results further support that post-conditioning activation of
NMDA receptors containing GluRε2 in the striatum were
crucial for the auditory fear memory formation with a
lower-intensity footshock. This finding is consistent
with the observation that GluRε2 predominates GluRε1/
GluN2A in NMDA receptors of the striatum [20].
Intra-striatum infusion of anisomycin impaired the
formation of auditory fear memory
We then asked whether protein synthesis in the striatum
is involved in long-term fear memory. We infused
anisomycin (62.5 μg in 0.5 μl) into the striatum
Figure 3 Impairment of long-term auditory fear memory by
post-training intra-striatum infusion of ifenprodil. (A)
Experimental design. Mice were injected with 0.5 μl of ACSF or
ifenprodil into the striatum immediately after auditory fear
conditioning with a footshock at 0.3 mA or 1.0 mA, and tested 24 h
later. (B) Freezing responses of ACSF (n = 17) and ifenprodil (n = 16)
groups conditioned with a low-intensity footshock (0.3 mA) on the
conditioning (left) and test (right) days. There was a significant
difference in the extent of the freezing responses between ACSF-
and ifenprodil-treated mice (F1,31 = 7.19, P = 0.01, repeated measures
ANOVA). (C) Freezing responses of ACSF (n = 9) and APV (n = 9)
groups conditioned with a footshock at 1.0 mA on the conditioning
(left) and test (right) days. The freezing responses of two groups of
mice were comparable (F1,16 = 0.12, P = 0.74, repeated measures
ANOVA). Solid lines and thick arrows represent tone and
footshock, respectively.
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ment with a protein synthesis inhibitor diminished freez-
ing responses to the conditioned stimulus (CS) in the
test 24 h following conditioning (Figure 4B; F1,13 = 9.3,
P = 0.009, n = 8 (ACSF) or 7 (anisomycin), repeated
measures ANOVA).We then tested whether a time window also exists in
the striatum, by delaying anisomycin infusions (62.5 μg)
for 1 or 3 h after conditioning. Anisomycin infusion 1 h
after conditioning produced a decrease in freezing in
response to the CS in the test (Figure 4C; F1,15 = 5.15,
P = 0.038, n = 9, compared to ACSF group in Figure 4B).
In contrast, infusion 3 h after conditioning had no effect
(Figure 4D; F1,12 = 0.22, P = 0.65, n = 6). It should be
noted that the impairment produced by delaying aniso-
mycin infusion is much smaller than that seen when
anisomycin is given immediately after learning (Figure 4D).
No effect of anisomycin treatment 3 h after training in-
dicated that behavioral impairment by immediate post-
training treatment cannot be explained as a side-effect of
drug infusions. Thus, consolidation has a time window
within 3 h which protein synthesis is required for the
long-term fear memory. We further confirmed that the
treatment of anisomycin did not affect the long-term
fear memory trained with a high-intensity shock, as above
(Figure 4C; F1,12 = 0.50, P = 0.49, n = 7 each).
We evaluated the effects of the anisomycin treatments
on protein synthesis by Fos immunoreactivity in the CP,
NAc, piriform cortex (Pir) and lateral amygdala (LA)
(Figure 5A to C). Administration of anisomycin reduced
Chloro-APB-induced Fos expression in the overlying CP
and NAc significantly compared to control groups trea-
ted with ACSF (Figure 5D, E; P < 0.001, Mann-Whitney’s
U test), indicating that anisomycin treatments successfully
attenuated protein synthesis (Figure 4). This reduction in
Fos expression was evident in a roughly circular region
of 3 mm in diameter, around the tip of the injector.
Anisomycin were diffused to neighboring structures, such
as adjacent Pir (Figure 5F), but not to the amygdala
(Figure 5G). In fact, anisomycin treatments hardly affected
Fos expression in the LA. These results suggest that pro-
tein synthesis in the striatum within 3 h after conditioning
is required for the long-term fear memory.
We finally examined whether the US activates striatal
neurons by measuring Fos immunoreactivities. Mice were
subjected to auditory fear conditioning with or without
footshocks. Fos-immunoreactive cell densities in the NAc
increased according to the intensities of the US (Figure 6;
F2,51 = 13.8, P < 0.001, one-way ANOVA). These results
showed that footshocks activated striatal neurons in a
dose-dependent manner.
Discussion
We previously revealed that the ablation of striatal neu-
rons induced in the adult brain impairs the long-term,
but not short-term, memory for auditory fear conditio-
ning with a lower-intensity footshock [15]. In the present
study, we showed that the post-conditioning infusion of
NMDA receptor antagonists in the striatum attenuated
the conditioned fear trained with a lower-intensity
Figure 4 Post-training infusion of anisomycin into the striatum
impaired long-term fear memory. (A) Experimental design. Mice
were injected with 0.5 μl of ACSF or anisomycin into the striatum
immediately after auditory fear conditioning, and tested 24 h later.
(B) Freezing responses of ACSF (n = 8) and anisomycin (n = 7)
groups on the conditioning at 0.3 mA (left) and test (right) days.
Solid lines and a thin arrow represent tone and footshock,
respectively. (C), Mice were injected with ACSF or ANI immediately
after the conditioning or 1 h or 3 h after the conditioning (0.3 mA),
and tested 24 h later. Bar graph shows the average freezing
responses during tone presentation (3 min) of ACSF group with
ACSF injections right after conditioning (ACSF 0 h; n = 8 as in
Figure 5B), ANI groups with ANI injections immediately (ANI 0 h;
n = 7 as in Figure 5B) or 1 h (ANI 1 h; n = 9) or 3 h (ANI 3 h; n = 6)
after conditioning. The same data set as the ACSF group and ANI
groups in (B) are also shown. *, P < 0.05; **, P < 0.01. (D), Mice were
injected with ACSF or ANI into the striatum immediately after
auditory fear conditioning with a high-intensity footshock (1.0 mA),
and tested 24 h later. Freezing responses of ACSF (n = 7) and ANI
(n = 7) groups on the conditioning (left) and test (right) days. Solid
lines and a thick arrow represent tone and footshock (1.0 mA),
respectively. ANI, anisomycin; BLA, basolateral amygdala; CeA, central
amygdala; CP, caudate putamen.
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NMDA receptors are involved in the memory consolida-
tion rather than acquisition process. On the other hand,
NMDA receptors in the amygdala are postulated to be in-
volved in the acquisition process in the fear conditioning
[6,21]. In the striatum, NMDA receptors are required for
long-term potentiation and long-term depression, but play
little role in synaptic transmission [22-25]. Striatal neu-
rons receive massive glutamatergic afferents from the
amygdala, cerebral cortex and hippocampus [26,27]. It is
possible that the neuronal activities of other brain re-
gions that store the short-term memory may induce
NMDA receptor-dependent processes in the striatum
during the post-conditioning consolidation period.
We also showed that the inhibition of protein synthe-
sis in the striatum disrupted long-term fear memory
when mice were trained with a lower-intensity foot-
shock. There is considerable evidence that memory con-
solidation, the formation of a long-term memory, can be
disrupted by a treatment of protein synthesis inhibitor
given shortly after training, but that the same treatment
given several hours or days later has no effect [7,28].
Our results suggest that the consolidation of auditory
fear memory formed with a weak US requires NMDA
receptors and protein synthesis in the striatum. How-
ever, NMDA receptor antagonists and protein synthesis
inhibitor exerted little effects on the auditory fear con-
ditioning with a high-intensity footshock (1.0 mA), in
agreement with previous studies showing that the amyg-
dala but not the striatum plays a central role in the audi-
tory fear conditioning [1-4]. Thus, the involvement of
the striatum in the auditory fear memory is selective for
the conditioning with a lower-intensity footshock. The
Figure 5 Immunohistochemical analysis of Chloro-APB-induced Fos protein levels after anisomycin infusion into the striatum.
(A) Topographical organization of the CP, NAc, Pir and BLA. (B, C) Immunoreactivities to Fos in ACSF (left)- and anisomycin (right)-infused brains
illustrate the extents of protein synthesis inhibition by anisomycin. High magnification images of Fos immunoreactivities in the CP (D), NAc (E),
the Pir (F), and LA (G) in ACSF- and anisomycin-infused brains. Graphs are quantitative analysis of Fos-immunoreactive cell density. n = 8–10 slices
from 3 mice each. ANI, anisomycin; BLA, basolateral amygdala; CeA, central amygdale; CP, caudate putamen; LA, lateral amygdala; NAc, nucleus
accumbens; Pir, piriform cortex. Scale bar: 1.0 mm. (B); 0.2 mm (D). ***, P < 0.001.
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formation from the cerebral cortex and thalamus to fa-
cilitate selection of actions that achieve reward-seeking
outcomes and avoid aversive outcomes [29]. During
auditory fear conditioning, striatal neurons are acti-
vated by the aversive stimulus in a dose-dependent man-
ner (Figure 6). Despite the activation by footshocks, the
striatum is not essential for auditory fear conditioning
with standard US. It is likely that the amygdala system
predominates over the striatal one when mice were con-
ditioned with high-intensity footshocks. When the US
becomes weaker, it will be less threatening and more diffi-
cult for animals to judge whether it is dangerous enough
to be memorized. Our results suggest that the striatum is
required for integrating weak threatening information into
auditory fear memory formation.Conclusions
Post-conditioning activation of NMDA receptors and
protein synthesis in the striatum are required for the
memory consolidation of auditory fear conditioning at
low-intensity shock. These results suggest that the stri-
atum is crucial for the consolidation of auditory fear
memory when US is weak.Materials and methods
Animals
Male C57BL/6N mice (Clea Japan, Tokyo, Japan) of
8–12 weeks old (20–29 g) were used as subjects. Ani-
mals were individually housed under standard laboratory
conditions with a 12-h day/night cycle; light was swit-
ched on at 8:00 and room temperature was maintained
at 23 ± 1°C. Food and water were offered ad libitum.
The experiments were performed during light phase. All
animal procedures were approved by the Animal Care
and the Use Committee of Graduate School of Medicine,
the University of Tokyo (Approval #1721S062).Surgery
Surgery was conducted as described previously [17]. Mice
were anesthetized with ketamine (80 mg/kg, i.p.; Sankyo
Co., Tokyo, Japan) and xylazine (20 mg/kg i.p.; Bayer,
Tokyo, Japan), and fixed to a stereotaxic apparatus (David
Kopf, Tujunga, CA, USA). The animals were implan-
ted two single guide cannulae (26 gauge; C315GS-5-SPC,
Plastics One, Roanoke, VA, USA) into the NAc bila-
terally at an angle of ±10° (stereotaxic coordinates:
AP = +1.3 mm from bregma, ML = ±1.1 mm from
midline, DV = −3.6 mm from bregma), according to
Figure 6 Immunohistochemical analysis of c-Fos protein
expression after auditory fear conditioning with different
intensities of unconditioned stimuli in the striatum. (A) Two
hours after auditory fear conditioning with a footshock at 0 mA,
0.3 mA, or 1.0 mA, brains were sectioned and immunostained with
anti-c-Fos antibody (upper panels, green). The nuclei were stained
with SYTOX orange (middle panels, red). Representative images of
coronal sections of NAc are shown as separate images (upper and
middle panels) and merged images (lower panels). (B) Quantitative
analysis of c-Fos-immunoreactive cell density in NAc. n = 18 slices
from 3 mice each. Scale bar: 100 μm. * and **, P < 0.05 and P < 0.01.
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nula (33 gauge; C315DCS-5-SPC, Plastics One) for micro-
injection was inserted 1 mm below the tip of the guide
cannulae (ML = ±1.0 mm, DV = −4.5 mm). The cannulae
were fixed to the skull with dental cement. The animals
were allowed to recover for at least 5 days before condi-
tioning experiments.
Drugs and infusions
Artificial cerebrospinal fluid (ACSF) was consisted of
150 mM NaCl, 3 mM KCl, 1.4 mM CaCl2, 0.8 mM
MgCl2, 0.8 mM Na2HPO4, and 0.2 mM NaH2PO4(pH 7.4). DL-2-Amino-5-phosphonovaleric acid (APV)
(Sigma-Aldrich, MO, USA) was dissolved in ACSF at a
concentration of 10 mM [1,17]. Ifenprodil (Sigma-
Aldrich) was dissolved in distilled water and then diluted
with ACSF to produce a final concentration of 2 μg/μl.
Anisomycin was dissolved in equimolar HCl, diluted
with ACSF and adjusted to pH 7 with NaOH to produce
a final concentration of 125 μg/μl. During drug infu-
sions, mice were restrained lightly in the disposable vinyl
jacket (Braintree Scientific, Inc, MA, USA). Drug or
ACSF was infused at a rate of 0.2 μl/min using a micro-
injection pump (CMA/100, CMA/Microdialysis, Solna,
Sweden). The infusion cannulae were left in place for a
further 1 min to diffuse the drug from needle tip, and
the animal then returned to its home cage. Mice were
injected the micro-ruby solution (Invitrogen, Carlsbad,
CA, USA) and perfused 30 min later to examine dye
diffusion.
Auditory fear conditioning
Fear conditioning was tested using computer-controlled
fear conditioning system (CL-M2; O’Hara, Tokyo,
Japan), as described previously [15]. For paired condi-
tioning paradigm, mice were placed in the conditioning
chamber for 2 min and then a loud tone (65 dB, 10 kHz)
was presented for 1 min through a speaker on the ceil-
ing of the conditioning chest. At the end of the tone
presentation, the mice were given a scrambled electrical
footshock (0.3 or 1.0 mA, 1 s). One minute after
footshock, the mice were returned to their home cages.
For unpaired conditioning, mice were received the
footshock immediately after they placed in the condi-
tioning chamber and 2.5 min after the placement, the
loud tone was presented for 1 min. Twenty-four hours
after conditioning, mice were placed in a novel translu-
cent acryl chamber with paper chips surrounded by a
sound-attenuating black chest for 3 min and subse-
quently the tone was presented for 3 min. Bilateral drug
or ASCF infusions into the striatum took place when an-
imals were taken from a conditioning chamber immedi-
ately after the conditioning, except that anisomycin was
also injected 1 or 3 h after conditioning. Freezing be-
havior was defined as the absence of any visible move-
ment of the body and vibrissae except for movement
necessitated by respiration. Freezing time was sum-
mated and the percentage of freezing was calculated
per minute [15].
Histochemistry
Each animal received ACSF in one side of the striatum
and anisomycin in the contralateral one. Mice were
then systemically administered with selective D1 agonist
Chloro-APB (Sigma-Aldrich, 5 mg/kg, i.p.) and returned
to their home cages for 2 h. The effect of the D1
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tion of the immediate early gene Fos expression. Mice
were transcardially perfused with 4% paraformaldehyde
in 0.1 M phosphate buffered saline (PBS). Brains were
removed and post-fixed overnight in the same fixative.
Brains were cut into 50 μm-thick free floating sections
on a vibrating microtome (Leica Microsystems, Wetzlar,
Germany). Sections were treated with 0.3% H2O2 in PBS
for 20 min, washed in PBS, incubated with blocking
solution (10% normal goat serum in PBS) for 1 h and
further incubated with anti-Fos antibody (1:500, Merck
KGaA, Darmstadt, Germany) overnight at room tempe-
rature. After 3 washes in PBS, tissue sections were incu-
bated with the biotinylated secondary antibody (Nichirei,
Tokyo, Japan) for 2 h. After 3 washes in PBS, sections
were incubated in streptavidin-conjugated peroxidase
(Nichirei) for 1 h. Peroxidase was revealed by incubating
sections with 0.5 mg/ml 3-3′-diaminobenzidine (Sigma-
Aldrich) and 0.002% H2O2 in PBS for 2 min. Sections
were then mounted on glass slides, dehydrated in etha-
nol solutions and xylene, and coverslipped. The numbers
of Fos-positive cells were counted at the dorsolateral
part of CP, the dorsomedial part of NAc core, the Pir
(AP = 1.2 mm from bregma), and the LA (AP = −1.7 mm)
in the coronal brain sections. Only unequivocally stained
cells were counted using the ImageJ software by two ob-
servers blind to the origin of the sections.
Two hours after auditory fear conditioning with a
footshock at 0 mA, 0.3 mA, or 1.0 mA, brain sections
were prepared as described above. Sections were bloc-
king with PBS containing 5% normal goat serum, 1%
BSA, and 0.3% Triton-X for 1 h at room temperature
and further incubated with rabbit anti-c-Fos antibody
(1:10000, Oncogene Research Products, Cambridge, MA)
overnight at 4°C. After washing, the sections were incu-
bated with Alexa Fluor 488 goat anit-rabbit IgG (1:1000,
Molecular Probes, Eugene, OR) and SYTOX Orange
nucleic acid stain (1:15000, Molecular Probes) in PBS
containing 0.3% Triton-X for 2 h at room temperature.
Fluorescence images were taken with a confocal laser-
scanning microscope (TCS SP5; Leica Microsystems,
Wetzlar, Germany).Statistics
Data are Mean ± SEM. The statistics significance was
evaluated using Mann-Whitney’s U test, repeated mea-
sures ANOVA or one-way ANOVA followed by Tukey’s
post hoc test. The criterion for statistical significance was
P < 0.05.
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